Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates-Reference-Cited by-同舟云学术

Evaluation of the activity of cefepime/enmetazobactam against Enterobacterales bacteria collected in Europe from 2019 to 2021, including third-generation cephalosporin-resistant isolates

Published:2024-09 Issue: Volume:38 Page:71-82
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Morrissey Ian^ORCID,Hawser Stephen,Kothari Nimmi^ORCID,Dunkel Nathalie,Quevedo Juan,Belley Adam^ORCID,Henriksen Anne Santerre^ORCID,Attwood Marie^ORCID

Publisher

Elsevier BV

Reference23 articles.

1. WHO. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. https://www.who.int/publications/i/item/WHO-EMP-IAU-2017.12; 2017. Accessed June 20, 2024.

2. Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection;Castanheira;JAC Antimicrob Resist,2021

3. Longitudinal analysis of ESBL and carbapenemase carriage among Enterobacterales and Pseudomonas aeruginosa isolates collected in Europe as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance programme, 2013-17;Kazmierczak;J Antimicrob Chemother,2020

4. Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017-2019;Gales;J Antimicrob Chemother,2023

5. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E. coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial;Harris;JAMA,2018